AFMCX
Price
$14.00
Change
-$0.24 (-1.69%)
Updated
Sep 20 closing price
FSSNX
Price
$27.77
Change
-$0.31 (-1.10%)
Updated
Sep 20 closing price
Ad is loading...

AFMCX vs FSSNX

Header iconAFMCX vs FSSNX Comparison
Open Charts AFMCX vs FSSNXBanner chart's image
Acuitas US Microcap Institutional
Price$14.00
Change-$0.24 (-1.69%)
VolumeN/A
CapitalizationN/A
Fidelity Small Cap Index
Price$27.77
Change-$0.31 (-1.10%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AFMCX vs FSSNX Comparison Chart
Loading...
VS
AFMCX vs. FSSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFMCX is a Buy and FSSNX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. AFMCX (92.7M). FSSNX pays higher dividends than AFMCX: FSSNX (1.36) vs AFMCX (0.00). AFMCX was incepted earlier than FSSNX: AFMCX (10 years) vs FSSNX (13 years). AFMCX is a more actively managed with annual turnover of: 56.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than AFMCX: FSSNX (0) vs AFMCX (10000). FSSNX annual gain was more profitable for investors over the last year : 22.65 vs. AFMCX (16.62). FSSNX return over 5 years is better than : 44.62 vs. AFMCX (37.12).
AFMCXFSSNXAFMCX / FSSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years13 years-
Gain YTD4.0459.97241%
Front LoadN/AN/A-
Min. Initial Investment100000-
Min. Initial Investment IRAN/AN/A-
Net Assets92.7M27.3B0%
Annual Yield % from dividends0.001.36-
Returns for 1 year16.6222.6573%
Returns for 3 years-12.700.65-1,954%
Returns for 5 years37.1244.6283%
Returns for 10 years41.3084.2449%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.